NCT06112197

Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications

Study of Visceral Fat in Type 2diabetic Patients and Its Relation to Microvascular Complications

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Study the correlation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

Detailed description

The Metabolic Score for Insulin Resistance (METS-IR) is a metabolic index developed with the aim to quantify peripheral insulin sensitivity in humans; it was first described under the name METS-IR by Bello-Chavolla et al in 2018. It was developed by the Metabolic Research Disease Unit at the Institute National de Ciencias Médicas Salvador Zubirán and validated against the euglycemic hyperinsulinemic clamp and the frequently-sampled intravenous glucose tolerance test in Mexican population.It is a non-insulin-based alternative to insulin-based methods to quantify peripheral insulin sensitivity and an alternative to the Homeostatic Model Assessment (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI). Very limited research correlate between visceral obesity and microvascular complications in type 2 diabetic patients and how can the metabolic score for insulin resistance predict visceral obesity and microvascular complications in type2 diabetic patients. In this study the investigators will search for these correlations.

Conditions

• Visceral Fat
• Insulin Resistance

Timeline

• Start date: 2024-01-05
• Primary completion: 2025-01-05
• Completion: 2025-06-05
• First posted: 2023-11-01
• Last updated: 2023-11-02

Locations

1 site across 1 country: Egypt